FDA Inspection
CSL Behring AGCSL Behring AG – FDA Inspection, Feb 18, 2020
Record Details
This FDA Inspection record concerns CSL Behring AG, with an inspection on February 18, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CSL Behring AG
- Inspection Date
- February 18, 2020
- Product Type
- Biologics
View Company Profile
ID · efbc8f3e-ac1a-4bf9-95eb-afb9f2185271
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1121637
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of CSL Behring AG
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 13, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 29, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 19, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 2, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 19, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Behring AG
- FDA Inspection 1057840 - 2018-04-13
- FDA Inspection 990288 - 2016-09-29
- FDA Inspection 890258 - 2014-06-19
- FDA Inspection 769044 - 2012-02-02
- FDA Inspection 645082 - 2010-01-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.